Skip to main content

Peer Review reports

From: CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV

Original Submission
8 Jul 2016 Submitted Original manuscript
4 Oct 2017 Author responded Author comments - Chia-Chen Lin
3 Oct 2016 Reviewed Reviewer Report - Gamal El-Sayed Shiha
Resubmission - Version 2
4 Oct 2017 Submitted Manuscript version 2
1 Dec 2017 Author responded Author comments - Chia-Chen Lin
Resubmission - Version 3
1 Dec 2017 Submitted Manuscript version 3
Publishing
5 Dec 2017 Editorially accepted
29 Dec 2017 Article published 10.1186/s12876-017-0724-4

You can find further information about peer review here.

Back to article page